| Neuroimmune pharmacology T Ikezu, HE Gendelman Springer, 2016 | 54 | 2016 |
| Drug Delivery (book) AK Mitra, D Kwatra, AD Vadlapudi Jones & Bartlett Publishers, 2014 | 37 | 2014 |
| Encapsulation of an EP67-conjugated CTL peptide vaccine in nanoscale biodegradable particles increases the efficacy of respiratory immunization and affects the magnitude and … BVK Karuturi, SB Tallapaka, P Yeapuri, SM Curran, SD Sanderson, ... Molecular pharmaceutics 14 (5), 1469-1481, 2017 | 15 | 2017 |
| Pro-NP™ protect against TiO2 nanoparticle-induced phototoxicity in zebrafish model: exploring potential application for skin care MS Kim, M Stees, BVK Karuturi, S Vijayaraghavalu, RE Peterson, ... Drug delivery and translational research 7, 372-382, 2017 | 14 | 2017 |
| Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after … SB Tallapaka, BVK Karuturi, P Yeapuri, SM Curran, YA Sonawane, ... International journal of pharmaceutics 565, 242-257, 2019 | 10 | 2019 |
| Delivery of antioxidant enzymes for prevention of ultraviolet irradiation-induced epidermal damage B Hammiller, BVK Karuturi, C Miller, M Holmes, V Labhasetwar, ... Journal of Dermatological Science 88 (3), 373-375, 2017 | 8 | 2017 |
| Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant BVK Karuturi, SB Tallapaka, JA Phillips, SD Sanderson, JA Vetro Clinical Immunology, 2015 | 8 | 2015 |
| Controlled Drug Delivery SB Tallapaka, VK Karuturi, S Sotthivirat, JA Vetro Drug Delivery, 478 pages, 2014 | 3 | 2014 |
| Development of EP67-based mucosal vaccines against cytomegalovirus infection BVK Karuturi University of Nebraska Medical Center, 2014 | 1 | 2014 |
| Modifying the Surface of PLGA Nanospheres with the Novel Host-Derived Immunostimulant EP67 Increases the Efficacy of Respiratory Immunization with Nanosphere-Encapsulated Proteins P Yeapuri, SB Tallapaka, V Karuturi, J Vetro 2017 AAPS Annual Meeting and Exposition, 2017 | | 2017 |
| New generation of adjuvants for protection against disease and to combat bioterrorism SD Sanderson, JA Vetro, BVK Karuturi Neuroimmune Pharmacology, 819-830, 2017 | | 2017 |
| Surface Modification of PLGA Nanoparticles with the Novel Host-Derived Immunostimulant EP67 Increases Internalization and Activates BMDCs In Vitro S Tallapaka, BV Karuturi, P Yeapuri, S Sanderson, J Vetro AAPS Annual Meeting and Exposition 2015, 2015 | | 2015 |
Shailendra B. TallapakaAssociate Principal Scientist, Quantitative Pharmacology and Pharmacometrics, MerckVerified email at merck.com
